|
Blood
|
|
ADAMTS13
|
61.2%
|
Anti-cardiolipin antibody
|
12 U/mL
|
|
ADAMTS13 inhibitor
|
< 0.5 BU/mL
|
Lupus anticoagulant
|
1.2
|
|
Anti-lipopolysaccharide antibody
|
Negative
|
CMV antigenemia (C10/11)
|
Negative
|
|
Anti-dsDNA antibody
|
< 10 U/mL
|
CMV IgM
|
0.27 (negative)
|
|
Anti-Sm antibody
|
< 2.0 U/mL
|
EBV VCA IgG
|
40×
|
|
Anti-SS-A antibody
|
< 1.0 U/mL
|
EBV VCA IgM
|
< 10×
|
|
Anti-SS-B antibody
|
< 1.0 U/mL
|
EBV EBNA
|
10×
|
|
Anti-RNP antibody
|
< 2.0 U/mL
|
Influenza A virus
|
< 4×
|
|
Anti-centromere antibody
|
< 5.0
|
Influenza B virus
|
< 4×
|
|
Anti-Scl-70 antibody
|
< 1.0 U/mL
|
HIV-1/HIV-2 antibodies
|
Negative
|
|
Anti-Jo-1 antibody
|
< 1.0 U/mL
|
HIV-1 p24 antigen
|
Negative
|
|
MPO-ANCA
|
< 1.0 U/mL
|
VZV IgG
|
28.8 (positive)
|
|
PR3-ANCA
|
< 1.0 U/mL
|
VZV IgM
|
0.23 (negative)
|
|
Anti-GBM antibody
|
< 2.0 U/mL
|
Parvovirus B19 IgM
|
< 0.8
|
|
Feces
|
|
Shiga toxin
|
Negative
| | |
- GBM glomerular basement membrane, CMV cytomegalovirus, EBV Epstein-Barr virus, VCA viral capsid antigen, EBNA EB nuclear antigen, VZV varicella zoster virus
